Biomedical Materials Market in US 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	170 Pages	TechNavio	March, 2025	INF19848731

Best Price Guarantee
Price	from $2,500
Length	170 Pages
Publisher	TechNavio
Published Date	March, 2025
SKU	INF19848731

Biomedical Materials Market In US 2025-2029

The biomedical materials market in US is forecasted to grow by USD 4.61 billion during 2024-2029, accelerating at a CAGR of 6.1% during the forecast period. The report on the biomedical materials market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by aging population, expanding regenerative medicine and tissue engineering, and rising prevalence of chronic diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's biomedical materials market in US is segmented as below:

By Type

Metallic
Polymers
Ceramic
Natural

By Application

Orthopedic
Cardiovascular
Dental
Neurology
Others

By Geographical Landscape

North America

This study identifies the adoption of 3D-printable biomaterials as one of the prime reasons driving the biomedical materials market in US growth during the next few years. Also, development of bioresorbable materials and incorporation of nanotechnology will lead to sizable demand in the market.

The report on the biomedical materials market in US covers the following areas:

Biomedical Materials Market in US sizing
Biomedical Materials Market in US forecast
Biomedical Materials Market in US industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biomedical materials market in US vendors that include 3D Systems Corp., Allegheny Technologies Inc., BASF SE, Berkeley Advanced Biomaterials, Biomaterial USA LLC, Carpenter Technology Corp., Celanese Corp., ConvaTec Group PLC, CoorsTek Inc., Corbion nv, Covation Biomaterials LLC, Covestro AG, DSM-Firmenich AG, Evonik Industries AG, Hollister Inc., Integra LifeSciences Holdings Corp., KYOCERA Corp., Morgan Advanced Materials PLC, Regenity, and Smith and Nephew PLC. Also, the biomedical materials market in US analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Country Market Characteristics; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ billion); Data Table on US - Market size and forecast 2024-2029 ($ billion); Chart on US: Year-over-year growth 2024-2029 (%); Data Table on US: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Biomedical Materials Market in US 2019 - 2023; Historic Market Size - Data Table on Biomedical Materials Market in US 2019 - 2023 ($ billion); 5.2 Type segment analysis 2019 - 2023; Historic Market Size - Type Segment 2019 - 2023 ($ billion); 5.3 Application segment analysis 2019 - 2023; Historic Market Size - Application Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis: 6.1 Impact of AI on Biomedical Materials Market in US
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type: 8.1 Market segments; Chart on Type - Market share 2024-2029 (%); Data Table on Type - Market share 2024-2029 (%); 8.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 8.3 Metallic - Market size and forecast 2024-2029; Chart on Metallic - Market size and forecast 2024-2029 ($ billion); Data Table on Metallic - Market size and forecast 2024-2029 ($ billion); Chart on Metallic - Year-over-year growth 2024-2029 (%); Data Table on Metallic - Year-over-year growth 2024-2029 (%); 8.4 Polymers - Market size and forecast 2024-2029; Chart on Polymers - Market size and forecast 2024-2029 ($ billion); Data Table on Polymers - Market size and forecast 2024-2029 ($ billion); Chart on Polymers - Year-over-year growth 2024-2029 (%); Data Table on Polymers - Year-over-year growth 2024-2029 (%); 8.5 Ceramic - Market size and forecast 2024-2029; Chart on Ceramic - Market size and forecast 2024-2029 ($ billion); Data Table on Ceramic - Market size and forecast 2024-2029 ($ billion); Chart on Ceramic - Year-over-year growth 2024-2029 (%); Data Table on Ceramic - Year-over-year growth 2024-2029 (%); 8.6 Natural - Market size and forecast 2024-2029; Chart on Natural - Market size and forecast 2024-2029 ($ billion); Data Table on Natural - Market size and forecast 2024-2029 ($ billion); Chart on Natural - Year-over-year growth 2024-2029 (%); Data Table on Natural - Year-over-year growth 2024-2029 (%); 8.7 Market opportunity by Type; Market opportunity by Type ($ billion); Data Table on Market opportunity by Type ($ billion)
9 Market Segmentation by Application: 9.1 Market segments; Chart on Application - Market share 2024-2029 (%); Data Table on Application - Market share 2024-2029 (%); 9.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 9.3 Orthopedic - Market size and forecast 2024-2029; Chart on Orthopedic - Market size and forecast 2024-2029 ($ billion); Data Table on Orthopedic - Market size and forecast 2024-2029 ($ billion); Chart on Orthopedic - Year-over-year growth 2024-2029 (%); Data Table on Orthopedic - Year-over-year growth 2024-2029 (%); 9.4 Cardiovascular - Market size and forecast 2024-2029; Chart on Cardiovascular - Market size and forecast 2024-2029 ($ billion); Data Table on Cardiovascular - Market size and forecast 2024-2029 ($ billion); Chart on Cardiovascular - Year-over-year growth 2024-2029 (%); Data Table on Cardiovascular - Year-over-year growth 2024-2029 (%); 9.5 Dental - Market size and forecast 2024-2029; Chart on Dental - Market size and forecast 2024-2029 ($ billion); Data Table on Dental - Market size and forecast 2024-2029 ($ billion); Chart on Dental - Year-over-year growth 2024-2029 (%); Data Table on Dental - Year-over-year growth 2024-2029 (%); 9.6 Neurology - Market size and forecast 2024-2029; Chart on Neurology - Market size and forecast 2024-2029 ($ billion); Data Table on Neurology - Market size and forecast 2024-2029 ($ billion); Chart on Neurology - Year-over-year growth 2024-2029 (%); Data Table on Neurology - Year-over-year growth 2024-2029 (%); 9.7 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ billion); Data Table on Others - Market size and forecast 2024-2029 ($ billion); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 9.8 Market opportunity by Application; Market opportunity by Application ($ billion); Data Table on Market opportunity by Application ($ billion)
10 Customer Landscape: 10.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Drivers, Challenges, and Opportunity/Restraints: 11.1 Market drivers; 11.2 Market challenges; 11.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 11.4 Market opportunities/restraints
12 Competitive Landscape: 12.1 Overview; 12.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 12.3 Landscape disruption; Overview on factors of disruption; 12.4 Industry risks; Impact of key risks on business
13 Competitive Analysis: 13.1 Companies profiled; Companies covered; 13.2 Company ranking index; Company ranking index; 13.3 Market positioning of companies; Matrix on companies position and classification; 13.4 Allegheny Technologies Inc.; Allegheny Technologies Inc. - Overview; Allegheny Technologies Inc. - Business segments; Allegheny Technologies Inc. - Key offerings; Allegheny Technologies Inc. - Segment focus; SWOT; 13.5 BASF SE; BASF SE - Overview; BASF SE - Business segments; BASF SE - Key news; BASF SE - Key offerings; BASF SE - Segment focus; SWOT; 13.6 Berkeley Advanced Biomaterials; Berkeley Advanced Biomaterials - Overview; Berkeley Advanced Biomaterials - Product / Service; Berkeley Advanced Biomaterials - Key offerings; SWOT; 13.7 Carpenter Technology Corp.; Carpenter Technology Corp. - Overview; Carpenter Technology Corp. - Business segments; Carpenter Technology Corp. - Key offerings; Carpenter Technology Corp. - Segment focus; SWOT; 13.8 Celanese Corp.; Celanese Corp. - Overview; Celanese Corp. - Business segments; Celanese Corp. - Key news; Celanese Corp. - Key offerings; Celanese Corp. - Segment focus; SWOT; 13.9 ConvaTec Group Plc; ConvaTec Group Plc - Overview; ConvaTec Group Plc - Product / Service; ConvaTec Group Plc - Key offerings; SWOT; 13.10 CoorsTek Inc.; CoorsTek Inc. - Overview; CoorsTek Inc. - Product / Service; CoorsTek Inc. - Key offerings; SWOT; 13.11 Corbion nv; Corbion nv - Overview; Corbion nv - Business segments; Corbion nv - Key news; Corbion nv - Key offerings; Corbion nv - Segment focus; SWOT; 13.12 Covestro AG; Covestro AG - Overview; Covestro AG - Business segments; Covestro AG - Key news; Covestro AG - Key offerings; Covestro AG - Segment focus; SWOT; 13.13 DSM-Firmenich AG; DSM-Firmenich AG - Overview; DSM-Firmenich AG - Product / Service; DSM-Firmenich AG - Key offerings; SWOT; 13.14 Evonik Industries AG; Evonik Industries AG - Overview; Evonik Industries AG - Business segments; Evonik Industries AG - Key news; Evonik Industries AG - Key offerings; Evonik Industries AG - Segment focus; SWOT; 13.15 Hollister Inc.; Hollister Inc. - Overview; Hollister Inc. - Product / Service; Hollister Inc. - Key offerings; SWOT; 13.16 Integra LifeSciences Holdings Corp.; Integra LifeSciences Holdings Corp. - Overview; Integra LifeSciences Holdings Corp. - Business segments; Integra LifeSciences Holdings Corp. - Key news; Integra LifeSciences Holdings Corp. - Key offerings; Integra LifeSciences Holdings Corp. - Segment focus; SWOT; 13.17 KYOCERA Corp.; KYOCERA Corp. - Overview; KYOCERA Corp. - Business segments; KYOCERA Corp. - Key news; KYOCERA Corp. - Key offerings; KYOCERA Corp. - Segment focus; SWOT; 13.18 Regenity; Regenity - Overview; Regenity - Product / Service; Regenity - Key offerings; SWOT
14 Appendix: 14.1 Scope of the report; 14.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 14.3 Currency conversion rates for US$; Currency conversion rates for US$; 14.4 Research methodology; Research methodology; 14.5 Data procurement; Information sources; 14.6 Data validation; Data validation; 14.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 14.8 Data synthesis; Data synthesis; 14.9 360 degree market analysis; 360 degree market analysis; 14.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Country Market Characteristics; Exhibits4: Executive Summary - Chart on Market Segmentation by Type; Exhibits5: Executive Summary - Chart on Market Segmentation by Application; Exhibits6: Executive Summary - Chart on Company Market Positioning; Exhibits7: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits8: Overview on criticality of inputs and factors of differentiation; Exhibits9: Overview on factors of disruption; Exhibits10: Impact of drivers and challenges in 2024 and 2029; Exhibits11: Parent Market; Exhibits12: Data Table on - Parent Market; Exhibits13: Market characteristics analysis; Exhibits14: Value chain analysis; Exhibits15: Offerings of companies included in the market definition; Exhibits16: Market segments; Exhibits17: Chart on US - Market size and forecast 2024-2029 ($ billion); Exhibits18: Data Table on US - Market size and forecast 2024-2029 ($ billion); Exhibits19: Chart on US: Year-over-year growth 2024-2029 (%); Exhibits20: Data Table on US: Year-over-year growth 2024-2029 (%); Exhibits21: Historic Market Size - Data Table on Biomedical Materials Market in US 2019 - 2023 ($ billion); Exhibits22: Historic Market Size - Type Segment 2019 - 2023 ($ billion); Exhibits23: Historic Market Size - Application Segment 2019 - 2023 ($ billion); Exhibits24: Five forces analysis - Comparison between 2024 and 2029; Exhibits25: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits26: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits27: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits28: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits29: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits30: Chart on Market condition - Five forces 2024 and 2029; Exhibits31: Chart on Type - Market share 2024-2029 (%); Exhibits32: Data Table on Type - Market share 2024-2029 (%); Exhibits33: Chart on Comparison by Type; Exhibits34: Data Table on Comparison by Type; Exhibits35: Chart on Metallic - Market size and forecast 2024-2029 ($ billion); Exhibits36: Data Table on Metallic - Market size and forecast 2024-2029 ($ billion); Exhibits37: Chart on Metallic - Year-over-year growth 2024-2029 (%); Exhibits38: Data Table on Metallic - Year-over-year growth 2024-2029 (%); Exhibits39: Chart on Polymers - Market size and forecast 2024-2029 ($ billion); Exhibits40: Data Table on Polymers - Market size and forecast 2024-2029 ($ billion); Exhibits41: Chart on Polymers - Year-over-year growth 2024-2029 (%); Exhibits42: Data Table on Polymers - Year-over-year growth 2024-2029 (%); Exhibits43: Chart on Ceramic - Market size and forecast 2024-2029 ($ billion); Exhibits44: Data Table on Ceramic - Market size and forecast 2024-2029 ($ billion); Exhibits45: Chart on Ceramic - Year-over-year growth 2024-2029 (%); Exhibits46: Data Table on Ceramic - Year-over-year growth 2024-2029 (%); Exhibits47: Chart on Natural - Market size and forecast 2024-2029 ($ billion); Exhibits48: Data Table on Natural - Market size and forecast 2024-2029 ($ billion); Exhibits49: Chart on Natural - Year-over-year growth 2024-2029 (%); Exhibits50: Data Table on Natural - Year-over-year growth 2024-2029 (%); Exhibits51: Market opportunity by Type ($ billion); Exhibits52: Data Table on Market opportunity by Type ($ billion); Exhibits53: Chart on Application - Market share 2024-2029 (%); Exhibits54: Data Table on Application - Market share 2024-2029 (%); Exhibits55: Chart on Comparison by Application; Exhibits56: Data Table on Comparison by Application; Exhibits57: Chart on Orthopedic - Market size and forecast 2024-2029 ($ billion); Exhibits58: Data Table on Orthopedic - Market size and forecast 2024-2029 ($ billion); Exhibits59: Chart on Orthopedic - Year-over-year growth 2024-2029 (%); Exhibits60: Data Table on Orthopedic - Year-over-year growth 2024-2029 (%); Exhibits61: Chart on Cardiovascular - Market size and forecast 2024-2029 ($ billion); Exhibits62: Data Table on Cardiovascular - Market size and forecast 2024-2029 ($ billion); Exhibits63: Chart on Cardiovascular - Year-over-year growth 2024-2029 (%); Exhibits64: Data Table on Cardiovascular - Year-over-year growth 2024-2029 (%); Exhibits65: Chart on Dental - Market size and forecast 2024-2029 ($ billion); Exhibits66: Data Table on Dental - Market size and forecast 2024-2029 ($ billion); Exhibits67: Chart on Dental - Year-over-year growth 2024-2029 (%); Exhibits68: Data Table on Dental - Year-over-year growth 2024-2029 (%); Exhibits69: Chart on Neurology - Market size and forecast 2024-2029 ($ billion); Exhibits70: Data Table on Neurology - Market size and forecast 2024-2029 ($ billion); Exhibits71: Chart on Neurology - Year-over-year growth 2024-2029 (%); Exhibits72: Data Table on Neurology - Year-over-year growth 2024-2029 (%); Exhibits73: Chart on Others - Market size and forecast 2024-2029 ($ billion); Exhibits74: Data Table on Others - Market size and forecast 2024-2029 ($ billion); Exhibits75: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits76: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits77: Market opportunity by Application ($ billion); Exhibits78: Data Table on Market opportunity by Application ($ billion); Exhibits79: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits80: Impact of drivers and challenges in 2024 and 2029; Exhibits81: Overview on criticality of inputs and factors of differentiation; Exhibits82: Overview on factors of disruption; Exhibits83: Impact of key risks on business; Exhibits84: Companies covered; Exhibits85: Company ranking index; Exhibits86: Matrix on companies position and classification; Exhibits87: Allegheny Technologies Inc. - Overview; Exhibits88: Allegheny Technologies Inc. - Business segments; Exhibits89: Allegheny Technologies Inc. - Key offerings; Exhibits90: Allegheny Technologies Inc. - Segment focus; Exhibits91: SWOT; Exhibits92: BASF SE - Overview; Exhibits93: BASF SE - Business segments; Exhibits94: BASF SE - Key news; Exhibits95: BASF SE - Key offerings; Exhibits96: BASF SE - Segment focus; Exhibits97: SWOT; Exhibits98: Berkeley Advanced Biomaterials - Overview; Exhibits99: Berkeley Advanced Biomaterials - Product / Service; Exhibits100: Berkeley Advanced Biomaterials - Key offerings; Exhibits101: SWOT; Exhibits102: Carpenter Technology Corp. - Overview; Exhibits103: Carpenter Technology Corp. - Business segments; Exhibits104: Carpenter Technology Corp. - Key offerings; Exhibits105: Carpenter Technology Corp. - Segment focus; Exhibits106: SWOT; Exhibits107: Celanese Corp. - Overview; Exhibits108: Celanese Corp. - Business segments; Exhibits109: Celanese Corp. - Key news; Exhibits110: Celanese Corp. - Key offerings; Exhibits111: Celanese Corp. - Segment focus; Exhibits112: SWOT; Exhibits113: ConvaTec Group Plc - Overview; Exhibits114: ConvaTec Group Plc - Product / Service; Exhibits115: ConvaTec Group Plc - Key offerings; Exhibits116: SWOT; Exhibits117: CoorsTek Inc. - Overview; Exhibits118: CoorsTek Inc. - Product / Service; Exhibits119: CoorsTek Inc. - Key offerings; Exhibits120: SWOT; Exhibits121: Corbion nv - Overview; Exhibits122: Corbion nv - Business segments; Exhibits123: Corbion nv - Key news; Exhibits124: Corbion nv - Key offerings; Exhibits125: Corbion nv - Segment focus; Exhibits126: SWOT; Exhibits127: Covestro AG - Overview; Exhibits128: Covestro AG - Business segments; Exhibits129: Covestro AG - Key news; Exhibits130: Covestro AG - Key offerings; Exhibits131: Covestro AG - Segment focus; Exhibits132: SWOT; Exhibits133: DSM-Firmenich AG - Overview; Exhibits134: DSM-Firmenich AG - Product / Service; Exhibits135: DSM-Firmenich AG - Key offerings; Exhibits136: SWOT; Exhibits137: Evonik Industries AG - Overview; Exhibits138: Evonik Industries AG - Business segments; Exhibits139: Evonik Industries AG - Key news; Exhibits140: Evonik Industries AG - Key offerings; Exhibits141: Evonik Industries AG - Segment focus; Exhibits142: SWOT; Exhibits143: Hollister Inc. - Overview; Exhibits144: Hollister Inc. - Product / Service; Exhibits145: Hollister Inc. - Key offerings; Exhibits146: SWOT; Exhibits147: Integra LifeSciences Holdings Corp. - Overview; Exhibits148: Integra LifeSciences Holdings Corp. - Business segments; Exhibits149: Integra LifeSciences Holdings Corp. - Key news; Exhibits150: Integra LifeSciences Holdings Corp. - Key offerings; Exhibits151: Integra LifeSciences Holdings Corp. - Segment focus; Exhibits152: SWOT; Exhibits153: KYOCERA Corp. - Overview; Exhibits154: KYOCERA Corp. - Business segments; Exhibits155: KYOCERA Corp. - Key news; Exhibits156: KYOCERA Corp. - Key offerings; Exhibits157: KYOCERA Corp. - Segment focus; Exhibits158: SWOT; Exhibits159: Regenity - Overview; Exhibits160: Regenity - Product / Service; Exhibits161: Regenity - Key offerings; Exhibits162: SWOT; Exhibits163: Inclusions checklist; Exhibits164: Exclusions checklist; Exhibits165: Currency conversion rates for US$; Exhibits166: Research methodology; Exhibits167: Information sources; Exhibits168: Data validation; Exhibits169: Validation techniques employed for market sizing; Exhibits170: Data synthesis; Exhibits171: 360 degree market analysis; Exhibits172: List of abbreviations